Related Experiment Video
Updated: May 12, 2026

07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Protein encapsulation in and release from monodisperse double-wall polymer microspheres
Yujie Xia1, Qingxing Xu, Chi-Hwa Wang
1Department of Chemical and Biomolecular Engineering, University of Illinois, Urbana, Illinois 61801, USA.
Journal of Pharmaceutical Sciences
|March 27, 2013
Summary
Biodegradable polymer double-wall microspheres (DWMS) offer controlled drug delivery. A drug-free shell extended protein release from 50 to 80 days, enhancing therapeutic potential.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Polymer Chemistry
Background:
- Biodegradable polymer double-wall microspheres (DWMS) are advanced carriers for macromolecular therapeutics like proteins and peptides.
- Precision Particle Fabrication (PPF) technology enables the creation of uniform microspheres with controlled structures.
Purpose of the Study:
- To fabricate and characterize biodegradable polymer double-wall microspheres (DWMS) for enhanced macromolecular therapeutic delivery.
- To investigate the impact of a drug-free poly(lactic acid) (PLA) shell on protein encapsulation and release kinetics.
Main Methods:
- Fabrication of uniform DWMS (approx. 55 μm outer diameter) using PPF technology, with poly(lactide-co-glycolide) cores encapsulating bovine serum albumin (BSA) and PLA shells.
- Utilized differential solvent extraction (ethyl acetate for shell, dichloromethane for core) to achieve distinct core-shell structures.
- Analyzed initial protein distribution, particle erosion, and in vitro protein release profiles for both DWMS and single-wall microspheres (SWMS).
Main Results:
- DWMS exhibited well-defined core-shell structures, high BSA encapsulation efficiency, and successful protein localization within the core.
- The presence of a drug-free PLA shell significantly reduced the protein release rate compared to SWMS.
- Protein release duration was extended from approximately 50 days to 70-80 days with the DWMS formulation.
Conclusions:
- Biodegradable polymer DWMS fabricated with PPF technology provide effective encapsulation and controlled release of protein therapeutics.
- The drug-free shell in DWMS acts as a barrier, significantly extending the release duration and improving therapeutic delivery control.
- These findings highlight the potential of DWMS for developing sustained-release formulations for protein and peptide drugs.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

